Last 12 months
Inside the activity.
4 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2022 Filed Feb 24, 2022 02:23 UTC |
Perez Edith A.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 210,000 | $0.00 Strike: $3.08 | $0.00 |
DisclosureSEC source: 0000899243-22-007526 · doc4.xml · derivative · entry 1 Perez Edith A. · CIK 0001821419 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,000 Underlying: Common Stock · 210,000 shares Expires 2032-02-17 F1 · derivative.exercise_date: For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2022. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 02:22 UTC |
Yonehiro GrantChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 190,000 | $0.00 Strike: $3.08 | $0.00 |
DisclosureSEC source: 0000899243-22-007525 · doc4.xml · derivative · entry 1 Yonehiro Grant · CIK 0001428666 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2032-02-17 F1 · derivative.exercise_date: For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2022. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 02:19 UTC |
Dornan DavidChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 210,000 | $0.00 Strike: $3.08 | $0.00 |
DisclosureSEC source: 0000899243-22-007520 · doc4.xml · derivative · entry 1 Dornan David · CIK 0001821353 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,000 Underlying: Common Stock · 210,000 shares Expires 2032-02-17 F1 · derivative.exercise_date: For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2022. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 02:18 UTC |
Schatzman Randall CDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 630,000 | $0.00 Strike: $3.08 | $0.00 |
DisclosureSEC source: 0000899243-22-007519 · doc4.xml · derivative · entry 1 Schatzman Randall C · CIK 0001604763 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630,000 Underlying: Common Stock · 630,000 shares Expires 2032-02-17 F1 · derivative.exercise_date: For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2022. Read SEC document |
| December 22, 2021 Filed Feb 2, 2022 00:18 UTC |
Perez Edith A.Chief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,714 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0000899243-22-003917 · doc4.xml · derivative · entry 4 Perez Edith A. · CIK 0001821419 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,286 Underlying: Common Stock · 35,714 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on the one year anniversary of April 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the Reporting Person continuing to be a service provider through each such date. Read SEC document |
| December 22, 2021 Filed Feb 2, 2022 00:18 UTC |
Perez Edith A.Chief Medical Officer
|
Exercise / conversionCommon Stock | 35,714 | $2.80 | $99,999.20 |
DisclosureSEC source: 0000899243-22-003917 · doc4.xml · nonDerivative · entry 3 Perez Edith A. · CIK 0001821419 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:20 UTC |
ONETTO NICOLEDirector
|
GrantStock Option (Right to Buy) · Derivative | 27,860 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0000899243-21-048601 · doc4.xml · derivative · entry 1 ONETTO NICOLE · CIK 0001220049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,860 Underlying: Common Stock · 27,860 shares Expires 2031-12-13 F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of December 14, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer. Read SEC document |
| December 08, 2021 Filed Dec 9, 2021 16:05 UTC |
Quinn William P.Chief Financial Officer
|
PurchaseCommon Stock | 5,000 | $4.72 | $23,575.00 |
DisclosureSEC source: 0000899243-21-047518 · doc4.xml · nonDerivative · entry 3 Quinn William P. · CIK 0001724190 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,154 Read SEC document |
| December 06, 2021 Filed Dec 9, 2021 16:05 UTC |
Quinn William P.Chief Financial Officer
|
PurchaseCommon Stock | 35 | $4.64 | $162.40 |
DisclosureSEC source: 0000899243-21-047518 · doc4.xml · nonDerivative · entry 2 Quinn William P. · CIK 0001724190 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,154 F1 · shares: Shares acquired under the issuer's Employee Stock Purchase Plan. Read SEC document |
| December 06, 2021 Filed Feb 2, 2022 00:18 UTC |
Perez Edith A.Chief Medical Officer
|
PurchaseCommon Stock | 411 | $4.64 | $1,907.04 |
DisclosureSEC source: 0000899243-22-003917 · doc4.xml · nonDerivative · entry 2 Perez Edith A. · CIK 0001821419 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,328 F1 · shares: These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c). Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 22:35 UTC |
Lee Frank D.Director
|
GrantStock Option (Right to Buy) · Derivative | 27,860 | $0.00 Strike: $9.01 | $0.00 |
DisclosureSEC source: 0001209191-21-065892 · doc4.xml · derivative · entry 1 Lee Frank D. · CIK 0001814686 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,860 Underlying: Common Stock · 27,860 shares Expires 2031-11-16 F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of November 17, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 22:28 UTC |
O'CALLAGHAN BRIANDirector
|
GrantStock Option (Right to Buy) · Derivative | 27,860 | $0.00 Strike: $9.01 | $0.00 |
DisclosureSEC source: 0001209191-21-065887 · doc4.xml · derivative · entry 1 O'CALLAGHAN BRIAN · CIK 0001415015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,860 Underlying: Common Stock · 27,860 shares Expires 2031-11-16 F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of November 17, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer. Read SEC document |
| June 04, 2021 Filed Dec 9, 2021 16:05 UTC |
Quinn William P.Chief Financial Officer
|
PurchaseCommon Stock | 1,221 | $16.65 | $20,329.65 |
DisclosureSEC source: 0000899243-21-047518 · doc4.xml · nonDerivative · entry 1 Quinn William P. · CIK 0001724190 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,119 F1 · shares: Shares acquired under the issuer's Employee Stock Purchase Plan. Read SEC document |
| June 04, 2021 Filed Feb 2, 2022 00:18 UTC |
Perez Edith A.Chief Medical Officer
|
PurchaseCommon Stock | 917 | $16.65 | $15,268.05 |
DisclosureSEC source: 0000899243-22-003917 · doc4.xml · nonDerivative · entry 1 Perez Edith A. · CIK 0001821419 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 917 F1 · shares: These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c). Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:35 UTC |
LAPORTE KATHLEENDirector
|
PurchaseCommon Stock | 1,200 | $20.00 | $24,000.00 |
DisclosureSEC source: 0001209191-21-008756 · doc4.xml · nonDerivative · entry 1 LAPORTE KATHLEEN · CIK 0001196201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
OtherWarrant (Right to Buy) · Derivative | 5,655 | $0.00 Strike: $0.07 | $0.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · derivative · entry 28 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Surplus Fund VIII, L.P. Disclosed balance after: 0 Underlying: Common Stock · 5,655 shares Expires 2028-07-26 F12 · derivative.exercise_date: The shares subject to this warrant were fully vested prior to exercise. F9 · ownership.nature: The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionSeries C-2 Preferred Stock · Derivative | 47,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · derivative · entry 27 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Surplus Fund VIII, L.P. Disclosed balance after: 0 Underlying: Common Stock · 47,718 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F7 · derivative.exercise_date: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F7 · derivative.expiration_date: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F9 · ownership.nature: The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionSeries C-1 Preferred Stock · Derivative | 43,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · derivative · entry 26 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Surplus Fund VIII, L.P. Disclosed balance after: 0 Underlying: Common Stock · 43,901 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F6 · derivative.exercise_date: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F6 · derivative.expiration_date: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F9 · ownership.nature: The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionSeries B Preferred Stock · Derivative | 150,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · derivative · entry 25 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Surplus Fund VIII, L.P. Disclosed balance after: 0 Underlying: Common Stock · 150,802 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F3 · derivative.exercise_date: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F3 · derivative.expiration_date: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F9 · ownership.nature: The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
OtherWarrant (Right to Buy) · Derivative | 40,953 | $0.00 Strike: $0.07 | $0.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · derivative · entry 24 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Fund VIII, L.P. Disclosed balance after: 0 Underlying: Common Stock · 40,953 shares Expires 2028-07-26 F12 · derivative.exercise_date: The shares subject to this warrant were fully vested prior to exercise. F5 · ownership.nature: The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionSeries C-2 Preferred Stock · Derivative | 345,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · derivative · entry 23 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Fund VIII, L.P. Disclosed balance after: 0 Underlying: Common Stock · 345,568 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F7 · derivative.exercise_date: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F7 · derivative.expiration_date: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F5 · ownership.nature: The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionSeries C-1 Preferred Stock · Derivative | 317,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · derivative · entry 22 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Fund VIII, L.P. Disclosed balance after: 0 Underlying: Common Stock · 317,922 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F6 · derivative.exercise_date: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F6 · derivative.expiration_date: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F5 · ownership.nature: The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionSeries B Preferred Stock · Derivative | 1,092,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · derivative · entry 21 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Fund VIII, L.P. Disclosed balance after: 0 Underlying: Common Stock · 1,092,080 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F3 · derivative.exercise_date: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F3 · derivative.expiration_date: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F5 · ownership.nature: The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
OtherWarrant (Right to Buy) · Derivative | 17,711 | $0.00 Strike: $0.07 | $0.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · derivative · entry 20 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo PANDA Fund, L.P. Disclosed balance after: 0 Underlying: Common Stock · 17,711 shares Expires 2028-07-26 F12 · derivative.exercise_date: The shares subject to this warrant were fully vested prior to exercise. F2 · ownership.nature: The securities reported herein are held of record by Vivo PANDA Fund, L.P. ("Vivo LP"). Vivo Panda, LLC ("Vivo LLC") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionSeries B Preferred Stock · Derivative | 472,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · derivative · entry 19 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo PANDA Fund, L.P. Disclosed balance after: 0 Underlying: Common Stock · 472,296 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F3 · derivative.exercise_date: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F3 · derivative.expiration_date: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F2 · ownership.nature: The securities reported herein are held of record by Vivo PANDA Fund, L.P. ("Vivo LP"). Vivo Panda, LLC ("Vivo LLC") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionSeries A-1 Preferred Stock · Derivative | 944,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · derivative · entry 18 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo PANDA Fund, L.P. Disclosed balance after: 0 Underlying: Common Stock · 944,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's initial public offering (the "IPO") and had no expiration date. F1 · derivative.exercise_date: The Series A-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's initial public offering (the "IPO") and had no expiration date. F1 · derivative.expiration_date: The Series A-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's initial public offering (the "IPO") and had no expiration date. F2 · ownership.nature: The securities reported herein are held of record by Vivo PANDA Fund, L.P. ("Vivo LP"). Vivo Panda, LLC ("Vivo LLC") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
PurchaseCommon Stock | 150,000 | $20.00 | $3,000,000.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 17 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Opportunity Fund, L.P. Disclosed balance after: 150,000 F11 · ownership.nature: The shares are held of record by Vivo Opportunity Fund, L.P. (VOF). Vivo Opportunity, LLC is the general partner of VOF and has four managing members. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
PurchaseCommon Stock | 24,267 | $20.00 | $485,340.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 16 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Surplus Fund VIII, L.P. Disclosed balance after: 275,789 F9 · ownership.nature: The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
SaleCommon Stock | 20 | $20.00 | $400.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 15 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Surplus Fund VIII, L.P. Disclosed balance after: 251,522 F10 · kind: Upon closing of the Issuer's IPO, Vivo Capital Surplus Fund VIII, L.P. exercised a warrant to purchase 5,655 shares of the Issuer's Common Stock at an exercise price per share of $0.07. Vivo Capital Surplus Fund VIII, L.P. paid the exercise price on a cashless basis, resulting in the Issuer withholding 20 share subject to the warrant in order to pay the exercise price and issuing to Vivo Capital Surplus Fund VIII, L.P. the remaining 5,635 shares of Common Stock. F9 · ownership.nature: The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
OtherCommon Stock | 5,655 | $0.07 | $395.85 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 14 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Surplus Fund VIII, L.P. Disclosed balance after: 251,542 F9 · ownership.nature: The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionCommon Stock | 47,718 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 13 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Surplus Fund VIII, L.P. Disclosed balance after: 245,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · price: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F9 · ownership.nature: The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionCommon Stock | 43,901 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 12 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Surplus Fund VIII, L.P. Disclosed balance after: 198,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F9 · ownership.nature: The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionCommon Stock | 150,802 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 11 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Surplus Fund VIII, L.P. Disclosed balance after: 154,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F9 · ownership.nature: The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
PurchaseCommon Stock | 175,733 | $20.00 | $3,514,660.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 10 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Fund VIII, L.P. Disclosed balance after: 1,997,216 F5 · ownership.nature: The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
SaleCommon Stock | 144 | $20.00 | $2,880.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 9 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Fund VIII, L.P. Disclosed balance after: 1,821,483 F8 · kind: Upon closing of the Issuer's IPO, Vivo Capital Fund VIII, L.P. exercised a warrant to purchase 40,953 shares of the Issuer's Common Stock at an exercise price per share of $0.07. Vivo Capital Fund VIII, L.P. paid the exercise price on a cashless basis, resulting in the Issuer withholding 144 share subject to the warrant in order to pay the exercise price and issuing to Vivo Capital Fund VIII, L.P. the remaining 40,809 shares of Common Stock. F5 · ownership.nature: The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
OtherCommon Stock | 40,953 | $0.07 | $2,866.71 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 8 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Fund VIII, L.P. Disclosed balance after: 1,821,627 F5 · ownership.nature: The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionCommon Stock | 345,568 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 7 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Fund VIII, L.P. Disclosed balance after: 1,780,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · price: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F5 · ownership.nature: The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionCommon Stock | 317,922 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 6 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Fund VIII, L.P. Disclosed balance after: 1,435,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F5 · ownership.nature: The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionCommon Stock | 1,092,080 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 5 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Capital Fund VIII, L.P. Disclosed balance after: 1,117,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F5 · ownership.nature: The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
SaleCommon Stock | 62 | $20.00 | $1,240.00 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 4 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo PANDA Fund, L.P. Disclosed balance after: 1,448,286 F4 · kind: Upon closing of the Issuer's IPO, Vivo LP exercised a warrant to purchase 17,711 shares of the Issuer's Common Stock at an exercise price per share of $0.07. Vivo LP paid the exercise price on a cashless basis, resulting in the Issuer withholding 62 share subject to the warrant in order to pay the exercise price and issuing to Vivo LP the remaining 17,649 shares of Common Stock. F2 · ownership.nature: The securities reported herein are held of record by Vivo PANDA Fund, L.P. ("Vivo LP"). Vivo Panda, LLC ("Vivo LLC") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
OtherCommon Stock | 17,711 | $0.07 | $1,239.77 |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 3 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo PANDA Fund, L.P. Disclosed balance after: 1,448,348 F2 · ownership.nature: The securities reported herein are held of record by Vivo PANDA Fund, L.P. ("Vivo LP"). Vivo Panda, LLC ("Vivo LLC") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionCommon Stock | 472,296 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 2 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo PANDA Fund, L.P. Disclosed balance after: 1,430,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F2 · ownership.nature: The securities reported herein are held of record by Vivo PANDA Fund, L.P. ("Vivo LP"). Vivo Panda, LLC ("Vivo LLC") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:37 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Panda Fund, L.P.10% owner
Vivo Panda, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
Vivo Opportunity, LLC10% owner
|
ConversionCommon Stock | 944,056 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-008758 · doc4.xml · nonDerivative · entry 1 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Panda Fund, L.P. · CIK 0001675490 · 10% owner Vivo Panda, LLC · CIK 0001843847 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo PANDA Fund, L.P. Disclosed balance after: 958,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's initial public offering (the "IPO") and had no expiration date. F2 · ownership.nature: The securities reported herein are held of record by Vivo PANDA Fund, L.P. ("Vivo LP"). Vivo Panda, LLC ("Vivo LLC") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 15:23 UTC |
Quinn William P.Chief Financial Officer
|
PurchaseCommon Stock | 1,200 | $20.00 | $24,000.00 |
DisclosureSEC source: 0001209191-21-008741 · doc4.xml · nonDerivative · entry 1 Quinn William P. · CIK 0001724190 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,898 Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 23:04 UTC |
Sofinnova Venture Partners X, L.P.10% owner
Sofinnova Management X, L.P.10% owner
Katabi Maha10% owner
POWELL MICHAEL10% owner
|
ConversionSeries C-2 Preferred Stock · Derivative | 1,200,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-016806 · tm215893d1_4.xml · derivative · entry 5 Sofinnova Venture Partners X, L.P. · CIK 0001680200 · 10% owner Sofinnova Management X, L.L.C. · CIK 0001680194 · 10% owner Katabi Maha · CIK 0001720685 · 10% owner POWELL MICHAEL · CIK 0001202793 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200,228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F3 · derivative.exercise_date: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F3 · derivative.expiration_date: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F2 · ownership.direct: The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 23:04 UTC |
Sofinnova Venture Partners X, L.P.10% owner
Sofinnova Management X, L.P.10% owner
Katabi Maha10% owner
POWELL MICHAEL10% owner
|
ConversionSeries C-1 Preferred Stock · Derivative | 1,104,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-016806 · tm215893d1_4.xml · derivative · entry 4 Sofinnova Venture Partners X, L.P. · CIK 0001680200 · 10% owner Sofinnova Management X, L.L.C. · CIK 0001680194 · 10% owner Katabi Maha · CIK 0001720685 · 10% owner POWELL MICHAEL · CIK 0001202793 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,104,209 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's initial public offering (the "IPO") and had no expiration date. F1 · derivative.exercise_date: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's initial public offering (the "IPO") and had no expiration date. F1 · derivative.expiration_date: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's initial public offering (the "IPO") and had no expiration date. F2 · ownership.direct: The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 23:04 UTC |
Sofinnova Venture Partners X, L.P.10% owner
Sofinnova Management X, L.P.10% owner
Katabi Maha10% owner
POWELL MICHAEL10% owner
|
PurchaseCommon Stock | 450,000 | $20.00 | $9,000,000.00 |
DisclosureSEC source: 0001104659-21-016806 · tm215893d1_4.xml · nonDerivative · entry 3 Sofinnova Venture Partners X, L.P. · CIK 0001680200 · 10% owner Sofinnova Management X, L.L.C. · CIK 0001680194 · 10% owner Katabi Maha · CIK 0001720685 · 10% owner POWELL MICHAEL · CIK 0001202793 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,754,437 F2 · ownership.direct: The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 23:04 UTC |
Sofinnova Venture Partners X, L.P.10% owner
Sofinnova Management X, L.P.10% owner
Katabi Maha10% owner
POWELL MICHAEL10% owner
|
ConversionCommon Stock | 1,200,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-016806 · tm215893d1_4.xml · nonDerivative · entry 2 Sofinnova Venture Partners X, L.P. · CIK 0001680200 · 10% owner Sofinnova Management X, L.L.C. · CIK 0001680194 · 10% owner Katabi Maha · CIK 0001720685 · 10% owner POWELL MICHAEL · CIK 0001202793 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,304,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date. F2 · ownership.direct: The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 23:04 UTC |
Sofinnova Venture Partners X, L.P.10% owner
Sofinnova Management X, L.P.10% owner
Katabi Maha10% owner
POWELL MICHAEL10% owner
|
ConversionCommon Stock | 1,104,209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-016806 · tm215893d1_4.xml · nonDerivative · entry 1 Sofinnova Venture Partners X, L.P. · CIK 0001680200 · 10% owner Sofinnova Management X, L.L.C. · CIK 0001680194 · 10% owner Katabi Maha · CIK 0001720685 · 10% owner POWELL MICHAEL · CIK 0001202793 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,104,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's initial public offering (the "IPO") and had no expiration date. F2 · ownership.direct: The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:33 UTC |
SHAH MAHENDRADirector
|
OtherWarrant (Right to Buy) · Derivative | 17,711 | $0.00 Strike: $0.07 | $0.00 |
DisclosureSEC source: 0001209191-21-008753 · doc4.xml · derivative · entry 7 SHAH MAHENDRA · CIK 0001255449 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo PANDA Fund, L.P. Disclosed balance after: 0 Underlying: Common Stock · 17,711 shares Expires 2028-07-26 F5 · derivative.exercise_date: The shares subject to this warrant were fully vested prior to exercise. F2 · ownership.nature: The securities reported herein are held of record by Vivo PANDA Fund, L.P. ("Vivo LP"). Vivo Panda, LLC ("Vivo LLC") is the sole general partner of Vivo LP. The Reporting Person is a managing member of Vivo LLC and has shared voting and investment power over the securities beneficially owned by Vivo LP and may therefore be deemed to have or share beneficial ownership of the securities held directly by Vivo LP. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.